Nova Patents
AT183397T

Compounds for medicinal use

Abstract

The invention relates to the use of muramyl peptides for the prophylaxis of cancer, in particular for the treatment of precancerous conditions associated with mucosal (mucosal) or epithelial cancer.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

23 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
9320820United KingdomA

Members23

Family members, oldest first
DocumentOfficeKind
GB9320820D0United KingdomD0
CA2173322A1CanadaA1
WO9510293A1World Intellectual Property Organization (WIPO)A1
AU7789094AAustraliaA
IL111198D0IsraelD0
ZA947894BSouth AfricaB
HU9600887D0HungaryD0
EP0722332A1European Patent Office (EPO)A1
CZ99796A3CzechiaA3
LV11595ALatviaA
BG100476ABulgariaA
SK42396A3SlovakiaA3
JPH09503776AJapanA
HUT75530AHungaryA
LV11595BLatviaB
AU680302B2AustraliaB2
US5877147AUnited States of AmericaA
EP0722332B1European Patent Office (EPO)B1
AT183397TThis recordAustriaT
DE69420145D1GermanyD1
DE69420145T2GermanyT2
KR100337977B1Republic of KoreaB1
JP3954644B2JapanB2